Prevalence and prevention of cardiovascular disease and diabetes mellitus

被引:395
|
作者
Balakumar, Pitchai [1 ]
Maung-U, Khin [2 ]
Jagadeesh, Gowraganahalli [2 ]
机构
[1] AIMST Univ, Pharmacol Unit, Fac Pharm, Bedong 08100, Kedah Darul Ama, Malaysia
[2] US FDA, Div Cardiovasc & Renal Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
关键词
Noncommunicable diseases; Cardiovascular risk factors; Cardiovascular disease prevalence; Diabetes mellitus; Disease prevention; CONGENITAL HEART-DISEASE; STROKE STATISTICS-2016 UPDATE; GLOBAL BURDEN; RISK-FACTORS; SCIENTIFIC STATEMENT; SYSTEMATIC ANALYSIS; ARTERY-DISEASE; ASSOCIATION; EPIDEMIOLOGY; HYPERTENSION;
D O I
10.1016/j.phrs.2016.09.040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Noncommunicable diseases (NCDs) have become important causes of mortality on a global scale. According to the report of World Health Organization (WHO), NCDs killed 38 million people (out of 56 million deaths that occurred worldwide) during 2012. Cardiovascular diseases accounted for most NCD deaths (17.5 million NCD deaths), followed by cancers (8.2 million NCD deaths), respiratory diseases (4.0 million NCD deaths) and diabetes mellitus (1.5 million NCD deaths). Globally, the leading cause of death is cardiovascular diseases; their prevalence is incessantly progressing in both developed and developing nations. Diabetic patients with insulin resistance are even at a greater risk of cardiovascular disease. Obesity, high cholesterol, hypertriglyceridemia and elevated blood pressure are mainly considered as major risk factors for diabetic patients afflicted with cardiovascular disease. The present review sheds light on the global incidence of cardiovascular disease and diabetes mellitus. Additionally, measures to be taken to reduce the global encumbrance of cardiovascular disease and diabetes mellitus are highlighted. Published by Elsevier Ltd.
引用
收藏
页码:600 / 609
页数:10
相关论文
共 50 条
  • [1] Diabetes mellitus and cardiovascular disease: strategies for prevention
    Grineva, Elena
    MINERVA ENDOCRINOLOGICA, 2016, 41 (04) : 401 - 402
  • [2] Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
    Newman, Jonathan D.
    Schwartzbard, Arthur Z.
    Weintraub, Howard S.
    Goldberg, Ira J.
    Berger, Jeffrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (07) : 883 - 893
  • [3] The secondary prevention of cardiovascular disease in diabetes mellitus patient
    Augello, Giuseppe
    Magnani, Luigi
    ITALIAN JOURNAL OF MEDICINE, 2015, 3 (06) : 379 - 389
  • [4] Aspirin for primary prevention of cardiovascular disease in diabetes mellitus
    Pignone, Michael
    Williams, Craig D.
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (11) : 619 - 628
  • [5] Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus
    Athanasakis, G.
    Papazafiropoulou, A.
    ARCHIVES OF HELLENIC MEDICINE, 2022, 39 (01): : 17 - 23
  • [6] Aspirin for primary prevention of cardiovascular disease in diabetes mellitus
    Michael Pignone
    Craig D. Williams
    Nature Reviews Endocrinology, 2010, 6 : 619 - 628
  • [7] Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus
    Colwell J.A.
    American Journal of Cardiovascular Drugs, 2004, 4 (2) : 87 - 106
  • [8] Diabetes mellitus and cardiovascular Prevention
    Kellerer, Monika
    Qui, Hui Jing
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (16) : 1033 - 1039
  • [9] Diabetes mellitus and cardiovascular prevention
    Kellerer, Monika
    Qiu, Hui Jing
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (05) : 345 - 355
  • [10] Cardiovascular disease prevention strategies for type 2 diabetes mellitus
    Katsiki, Niki
    Purrello, Francesco
    Tsioufis, Costas
    Mikhailidis, Dimitri P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (12) : 1243 - 1260